Research progress on the relationship between Toll-like receptor 2 and ischemic stroke

doi:10.3877/cma.j.issn.2095-123X.2023.01.007

Abstract

Abstract:

The pathophysiological mechanism of ischemic stroke is complex, and studies have shown that toll-like receptor 2 (TLR2)-mediated inflammatory response plays an important role in this process. By reviewing relevant literature, the biological function of TLR2 and its mediated signaling pathway as well as the research progress of the relationship between TLR2 and ischemic stroke were reviewed.

Key words: Ischemic stroke, Inflammation, Toll-like receptor 2

Haijie Gao, Baojun Wang. Research progress on the relationship between Toll-like receptor 2 and ischemic stroke[J]. Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition), 2023, 13(01): 57-61.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhnkjbykfzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-123X.2023.01.007

https://zhnkjbykfzz.cma-cmc.com.cn/EN/Y2023/V13/I01/57

References 52

[1]	Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults[J]. Circulation, 2017, 135(8): 759-771. DOI: 10.1161/CIRCULATIONAHA.116.025250.
[2]	都一鸣,陈鑫,赵世光.急性缺血性脑卒中氧化应激机制的研究进展[J].中华神经创伤外科电子杂志, 2021, 7(2): 121-124. DOI: 10.3877/cma.j.issn.2095-9141.2021.02.013.
[3]	Petrovic-Djergovic D, Goonewardena SN, Pinsky DJ. Inflammatory disequili-brium in stroke[J]. Circ Res. 2016, 119(1): 142-158. DOI: 10.1161/CIRCRESAHA.116.308022.
[4]	Satoh T, Akira S. Toll-like receptor signaling and its inducible proteins[J]. Microbiol Spectr, 2016, 4(6): 4.6.41. DOI: 10.1128/microbiolspec.MCHD-0040-2016.
[5]	Lim KH, Staudt LM. Toll-like receptor signaling[J]. Cold Spring Harb Perspect Biol, 2013, 5(1): a011247. DOI: 10.1101/cshperspect.a011247.
[6]	Wang Y, Ge P, Zhu Y. TLR2 and TLR4 in the brain injury caused by cerebral ischemia and reperfusion[J]. Mediators Inflamm, 2013, 2013: 124614. DOI: 10.1155/2013/124614.
[7]	Hakimizadeh E, Shamsizadeh A, Roohbakhsh A, et al. TRPV1 receptor-mediated expression of Toll-like receptors 2 and 4 following permanent middle cerebral artery occlusion in rats[J]. Iran J Basic Med Sci, 2017, 20(8): 863-869. DOI: 10.22038/IJBMS.2017.9107.
[8]	Sameer AS, Nissar S. Toll-like receptors (TLRs): structure, functions, signaling, and role of their polymorphisms in colorectal cancer susceptibility[J]. Biomed Res Int, 2021, 2021: 1157023. DOI: 10.1155/2021/1157023.
[9]	Zhang X, Hei Y, Bai W, et al. Toll-like receptor 2 attenuates traumatic brain injury-induced neural stem cell proliferation in dentate gyrus of rats[J]. Neural Plast, 2020, 2020: 9814978. DOI: 10.1155/2020/9814978.
[10]	Dutta D, Jana M, Majumder M, et al. Selective targeting of the TLR2/MyD88/NF-κB pathway reduces α-synuclein spreading in vitro and in vivo[J]. Nat Commun, 2021, 12(1): 5382. DOI: 10.1038/s41467-021-25767-1.
[11]	Zhao H, Lv J, Meng L, et al. Dual-specificity phosphatase 26-dificient neurons are susceptible to oxygen-glucose deprivation/reoxygenation-evoked apoptosis and proinflammatory response by affecting the TAK1-medaited JNK/P38 MAPK pathway[J]. Int Immunopharmacol, 2023, 117: 109980. DOI: 10.1016/j.intimp.2023.109980.
[12]	Köllisch G, Kalali BN, Voelcker V, et al. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes[J]. Immunology, 2005, 114(4): 531-541. DOI: 10.1111/j.1365-2567.2005.02122.x.
[13]	Roshan MH, Tambo A, Pace NP. The role of TLR2, TLR4, and TLR9 in the pathogenesis of atherosclerosis[J]. Int J Inflam, 2016, 2016: 1532832. DOI: 10.1155/2016/1532832.
[14]	奥婷,张芹,肖淑英,等. HMGB1与缺血性脑卒中关系的研究进展[J].医学综述, 2018, 24(9): 1681-1686. DOI: 10.3969/j.issn.1006-2084.2018.09.004.
[15]	Arya P, Bhandari U. Involvement of the toll-like receptors-2/nuclear factor-kappa B signaling pathway in atherosclerosis induced by high-fat diet and zymosan a in C57BL/6 mice[J]. Indian J Pharmacol, 2020, 52(3): 203-209. DOI: 10.4103/ijp.IJP_567_19.
[16]	周敏,陈智利,张丽丽,等.缺血性脑卒中后血脑屏障内皮跨细胞转运的调控机制及靶向治疗[J].中华神经医学杂志, 2022, 21(2): 189-194. DOI: 10.3760/cma.j.cn115354-20201103-00868.
[17]	Kurzepa J, Kurzepa J, Golab P, et al. The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke[J]. Int J Neurosci, 2014, 124(10): 707-716. DOI: 10.3109/00207454.2013.872102.
[18]	Zhu H, Dai R, Fu H, et al. MMP-9 upregulation is attenuated by the monoclonal TLR2 antagonist T2.5 after oxygen-glucose deprivation and reoxygenation in rat brain microvascular endothelial cells[J]. J Stroke Cerebrovasc Dis, 2019, 28(1): 97-106. DOI: 10.1016/j.jstrokecerebrovasdis.2018.09.014.
[19]	Huang H, Zhong R, Xia Z, et al. Neuroprotective effects of rhynchophylline against ischemic brain injury via regulation of the Akt/mTOR and TLRs signaling pathways[J]. Molecules, 2014, 19(8): 11196-11210. DOI: 10.3390/molecules190811196.
[20]	Sun W, Ding Z, Xu S, et al. Crosstalk between TLR2 and Sphk1 in microglia in the cerebral ischemia/reperfusion-induced inflammatory response[J]. Int J Mol Med, 2017, 40(6): 1750-1758. DOI: 10.3892/ijmm.2017.3165.
[21]	Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation[J]. Nat Med, 2011, 17(7): 796-808. DOI: 10.1038/nm.2399.
[22]	Ziegler G, Harhausen D, Schepers C, et al. TLR2 has a detrimental role in mouse transient focal cerebral ischemia[J]. Biochem Biophys Res Commun, 2007, 359(3): 574-579. DOI: 10.1016/j.bbrc.2007.05.157.
[23]	Zhang P, Cheng G, Chen L, et al. Cerebral hypoxia-ischemia increases toll-like receptor 2 and 4 expression in the hippocampus of neonatal rats[J]. Brain Dev, 2015, 37(8): 747-752. DOI: 10.1016/j.braindev.2014.12.001.
[24]	Anttila JE, Whitaker KW, Wires ES, et al. Role of microglia in ischemic focal stroke and recovery: focus on Toll-like receptors[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2017, 79(Pt A): 3-14. DOI: 10.1016/j.pnpbp.2016.07.003.
[25]	Huang Y, Cai B, Xu M, et al. Gene silencing of Toll-like receptor 2 inhibits proliferation of human liver cancer cells and secretion of inflammatory cytokines [J]. PLoS One, 2012, 7(7): e38890. DOI: 10.1371/journal.pone.0038890.
[26]	Nalamolu KR, Challa SR, Fornal CA, et al. Attenuation of the induction of TLRs 2 and 4 mitigates inflammation and promotes neurological recovery after focal cerebral ischemia[J]. Transl Stroke Res, 2021, 12(5): 923-936. DOI: 10.1007/s12975-020-00884-z.
[27]	王美娥,刘龙江,路永刚. Toll样受体对急性缺血性脑卒中临床疗效和预后的预测价值[J].中西医结合心脑血管病杂志, 2021, 19(5): 731-736. DOI: 10.12102/j.issn.1672-1349.2021.05.006.
[28]	Brea D, Blanco M, Ramos-Cabrer P, et al. Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values[J]. J Cereb Blood Flow Metab, 2011, 31(6): 1424-1431. DOI: 10.1038/jcbfm.2010.231.
[29]	Bohacek I, Cordeau P, Lalancette-Hébert M, et al. Toll-like receptor 2 deficiency leads to delayed exacerbation of ischemic injury[J]. J Neuroinflammation, 2012, 9: 191. DOI: 10.1186/1742-2094-9-191.
[30]	杨炎歌,段淑荣.脑梗死后VEGF及bFGF对神经干细胞增殖分化的机制研究进展[J].中国卒中杂志, 2016, 11(8): 704-708. DOI: 10.3969/j.issn.1673-5765.2016.08.018.
[31]	Moon S, Chang MS, Koh SH, et al. Repair mechanisms of the neurovascular unit after ischemic stroke with a focus on VEGF[J]. Int J Mol Sci, 2021, 22(16): 8543. DOI: 10.3390/ijms22168543.
[32]	刘琴.血管内皮生长因子、Toll样受体2与急性缺血性脑卒中颈动脉内膜中层增厚的相关性分析[J].实用医院临床杂志, 2021, 18(6): 169-172. DOI: 10.3969/j.issn.1672-6170.2021.06.048.
[33]	Qiu Y, Yin Q, Fei Y, et al. JLX001 modulated the inflammatory reaction and oxidative stress in pMCAO rats via inhibiting the TLR2/4-NF-κB signaling pathway[J]. Neurochem Res, 2019, 44(8): 1924-1938. DOI: 10.1007/s11064-019-02826-0.
[34]	Ling Y, Jin L, Ma Q, et al. Salvianolic acid a alleviated inflammatory response mediated by microglia through inhibiting the activation of TLR2/4 in acute cerebral ischemia-reperfusion[J]. Phytomedicine, 2021, 87: 153569. DOI: 10.1016/j.phymed.2011.153569.
[35]	Huang L, Chen C, Zhang X, et al. Neuroprotective effect of curcumin against cerebral ischemia-reperfusion Via mediating autophagy and inflammation[J]. J Mol Neurosci, 2018, 64(1): 129-139. DOI: 10.1007/s12031-017-1006-x.
[36]	Tu XK, Yang WZ, Shi SS, et al. Baicalin inhibits TLR2/4 signaling pathway in rat brain following permanent cerebral ischemia[J]. Inflammation, 2011, 34(5): 463-470. DOI: 10.1007/s10753-010-9254-8.
[37]	Gad SN, Nofal S, Raafat EM, et al. Lixisenatide reduced damage in hippocampus CA1 neurons in a rat model of cerebral ischemia-reperfusion possibly via the ERK/P38 signaling pathway[J]. J Mol Neurosci, 2020, 70(7): 1026-1037. DOI: 10.1007/s12031-020-01497-9.
[38]	Chen X, Arumugam TV, Cheng YL, et al. Combination therapy with low-dose IVIG and a C1-esterase inhibitor ameliorates brain damage and functional deficits in experimental ischemic stroke[J]. Neuromolecular Med, 2018, 20(1): 6372. DOI: 10.1007/s12017-017-8474-6.
[39]	Xu XJ, Long JB, Jin KY, et al. Danshen-Chuanxiongqin injection attenuates cerebral ischemic stroke by inhibiting neuroinflammation via the TLR2/TLR4-MyD88-NF-κB pathway in tMCAO mice[J]. Chin J Nat Med, 2021, 19(10): 772-783. DOI: 10.1016/S1875-5364(21)60083-3.
[40]	Xie W, Zhou P, Sun Y, et al. Protective effects and target network analysis of ginsenoside Rg1 in cerebral ischemia and reperfusion injury: a comprehensive overview of experimental studies[J]. Cells, 2018, 7(12): 270. DOI: 10.3390/cells7120270.
[41]	Chen H, Guan B, Wang B, et al. Glycyrrhizin prevents hemorrhagic transformation and improves neurological outcome in ischemic stroke with delayed thromb-olysis through targeting peroxynitrite-mediated HMGB1 signaling[J]. Transl Stroke Res, 2020, 11(5): 967-982. DOI: 10.1007/s12975-019-00772-1.
[42]	李倩楠,尚津锋,姜婷月,等.基于Toll样受体信号通路探讨脑心通胶囊"脑心同治"的作用机制[J].中国中药杂志, 2022, 47(15): 4110-4118. DOI: 10.19540/j.cnki.cjcmm.20220211.401.
[43]	张军,周佩洋.七叶皂苷钠联合氯吡格雷治疗急性缺血性脑卒中的临床研究[J].中西医结合心脑血管病杂志, 2020, 18(17): 2898-2901. DOI: 10.12102/j.issn.1672-1349.2020.17.039.
[44]	Tajalli-Nezhad S, Karimian M, Beyer C, et al. The regulatory role of Toll-like receptors after ischemic stroke: neurosteroids as TLR modulators with the focus on TLR2/4[J]. Cell Mol Life Sci, 2019, 76(3): 523-537. DOI: 10.1007/s00018-018-2953-2.
[45]	王艳,兰坚,何顺学.血清血管内皮生长因子、Toll样受体与颈动脉支架成形术治疗急性缺血性脑卒中患者预后的相关性研究[J].实用医院临床杂志, 2019, 16(1): 30-32. DOI: 10.3969/j.issn.1672-6170.2019.01.010.
[46]	Hu H, Zou C. Mesenchymal stem cells in renal ischemia-reperfusion injury: biological and therapeutic perspectives[J]. Curr Stem Cell Res Ther, 2017, 12(3): 183-187. DOI: 10.2174/1574888X11666161024143640.
[47]	刘霜月,张玉莲,许潇莹,等.基于Toll样受体2/核转录因子kappa B通路探讨电针对脑缺血损伤大鼠的作用机制[J].针刺研究, 2019, 44(4): 242-247. DOI: 10.13702/j.1000-0607.180553.
[48]	黄伟,李佳,朱广为.针刺百会、人中穴对急性脑缺血大鼠模型NF-κB/IκB-α的影响[J].中华中医药杂志, 2017, 32(1): 298-302.
[49]	Lee HI, Lee SW, Kim NG, et al. Low-level light emitting diode (LED) therapy suppresses inflammasome-mediated brain damage in experimental ischemic stroke[J]. J Biophotonics, 2017, 10(11): 1502-1513. DOI: 10.1002/jbio.201600244.
[50]	Ma W, Xie X, Shao X, et al. Tetrahedral DNA nanostructures facilitate neural stem cell migration via activating RHOA/ROCK2 signalling pathway[J]. Cell Prolif, 2018, 51(6): e12503. DOI: 10.1111/cpr.12503.
[51]	Ma W, Zhan Y, Zhang Y, et al. Enhanced neural regeneration with a concomitant treatment of framework nucleic acid and stem cells in spinal cord injury[J]. ACS Appl Mater Interfaces, 2020, 12(2): 2095-2106. DOI: 10.1021/acsami.9b19079.
[52]	Zhou M, Zhang T, Zhang B, et al. A DNA nanostructure-based neuroprotectant against neuronal apoptosis via inhibiting Toll-like receptor 2 signaling pathway in acute ischemic stroke[J]. ACS Nano, 2022, 16(1): 1456-1470. DOI: 10.1021/acsnano.1c09626.

Please choose a citation manager

Content to export